Australia markets open in 3 hours 57 minutes

ImmunoPrecise Antibodies Ltd. (TQB.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.1100-0.0300 (-2.63%)
At close: 08:28AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
30/04/2020
Total revenue
19,927
20,665
19,364
17,912
14,058
Cost of revenue
8,767
9,102
8,381
6,374
6,024
Gross profit
11,160
11,563
10,983
11,538
8,034
Operating expenses
Research development
13,158
12,280
7,663
1,974
446
Selling general and administrative
20,110
23,420
18,055
13,265
8,032
Total operating expenses
36,808
39,782
27,656
15,714
11,860
Operating income or loss
-25,648
-28,219
-16,673
-4,176
-3,826
Interest expense
378
30
85
863
1,437
Total other income/expenses net
475
227
631
-1,238
-82
Income before tax
-25,248
-27,752
-15,848
-5,995
-5,293
Income tax expense
-46
-1,192
861
1,345
-346
Income from continuing operations
-25,202
-26,560
-16,709
-7,340
-4,947
Net income
-25,202
-26,560
-16,709
-7,340
-4,947
Net income available to common shareholders
-25,202
-26,560
-16,709
-7,340
-4,947
Basic EPS
-0.65
-1.07
-0.85
-0.45
-0.36
Diluted EPS
-0.65
-1.07
-0.85
-0.45
-0.36
Basic average shares
25,019
24,897
19,688
16,474
13,629
Diluted average shares
25,019
24,897
19,688
16,474
13,629